Improved cardiac function and dietary fatty acid metabolism after modest weight loss in subjects with impaired glucose tolerance

American Journal of Physiology - Endocrinology and Metabolism

Volumn 306, Issue 12, 2014, Pages

  Labbé, Sébastien M ^a   Noll, Christophe ^a   Grenier Larouche, Thomas ^a   Kunach, Margaret ^a   Bouffard, Lucie ^a   Phoenix, Serge ^a   Guérin, Brigitte ^a   Baillargeon, Jean Patrice ^a   Langlois, Marie France ^a   Turcotte, Eric E ^a   Carpentier, André C ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Fatty acids; Food metabolism; Positron emission tomography

Indexed keywords

ACETIC ACID; CHYLOMICRON; FLUORO 6 THIA HEPTADECANOIC ACID F18; GLUCOSE; INSULIN; RADIOPHARMACEUTICAL AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; AEROBIC METABOLISM; AGE; AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FAT INTAKE; FATTY ACID METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICULOGRAPHY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIFESTYLE MODIFICATION; LIVER; MALE; METABOLITE; ORAL GLUCOSE TOLERANCE TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SYSTOLIC BLOOD PRESSURE; THIGH; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

FATTY ACIDS; FOOD METABOLISM; POSITRON EMISSION TOMOGRAPHY;

ACETIC ACID; BODY MASS INDEX; CARBON RADIOISOTOPES; COMBINED MODALITY THERAPY; DIET, REDUCING; DIETARY FATS; FATTY ACIDS; FEMALE; FLUORINE RADIOISOTOPES; GLUCOSE INTOLERANCE; HEART VENTRICLES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; POSITRON-EMISSION TOMOGRAPHY; POSTPRANDIAL PERIOD; RADIONUCLIDE VENTRICULOGRAPHY; RADIOPHARMACEUTICALS; VENTRICULAR DYSFUNCTION, LEFT; WEIGHT LOSS;

EID: 84902682901     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00638.2013     Document Type: Article

References (47)

1. Aasum E, Khalid AM, Gudbrandsen OA, How OJ, Berge RK, Larsen TS. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice. J Mol Cell Cardiol 44: 201-209, 2008.
2. Bickerton AS, Roberts R, Fielding BA, Hodson L, Blaak EE, Wagenmakers AJ, Gilbert M, Karpe F, Frayn KN. Preferential uptake of dietary Fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56: 168-176, 2007.
3. Bickerton AS, Roberts R, Fielding BA, Tornqvist H, Blaak EE, Wagenmakers AJ, Gilbert M, Humphreys SM, Karpe F, Frayn KN. Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 51: 1466-1474, 2008.
4. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223, 2007.
5. Brassard P, Frisch F, Lavoie F, Cyr D, Bourbonnais A, Cunnane SC, Patterson BW, Drouin R, Baillargeon JP, Carpentier AC. Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of type 2 diabetes. J Clin Endocrinol Metab 93: 837-844, 2008.
6. Carpentier AC, Labbe SM, Grenier-Larouche T, Noll C. Abnormal dietary fatty acid metabolic partitioning in insulin resistance and type 2 diabetes. Clin Lipidol 6: 703-716, 2011.
7. Ci X, Frisch F, Lavoie F, Germain P, Lecomte R, van Lier JE, Benard F, Carpentier AC. The effect of insulin on the intracellular distribution of 14(R, S)-[(18)F]Fluoro-6-thia-heptadecanoic acid in rats. Mol Imaging Biol 8: 237-244, 2006.
8. Croteau E, Lavallee E, Labbe SM, Hubert L, Pifferi F, Rousseau JA, Cunnane SC, Carpentier AC, Lecomte R, Benard F. Image-derived input function in dynamic human PET/CT: methodology and validation with (11)C-acetate and (18)F-fluorothioheptadecanoic acid in muscle and (18)F-fluorodeoxyglucose in brain. EurJ Nucl Med Mol Imaging 37: 1539-1550, 2010.
9. de las FL, Waggoner AD, Mohammed BS, Stein RI, Miller BV, III, Foster GD, Wyatt HR, Klein S, Davila-Roman VG. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol 54: 2376-2381, 2009.
10. Gagnon C, Brown C, Couture C, Kamga-Ngande CN, Hivert MF, Baillargeon JP, Carpentier AC, Langlois MF. A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes. Diabetes Metab 37: 410-418, 2011.
11. Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF. Lipidinduced pancreatic β-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab 300: E255-E262, 2011.
12. Jonker JT, Djaberi R, van Schinkel LD, Hammer S, Bus MT, Kerpershoek G, Kharagjitsingh AV, Romijn JA, Bax JJ, Jukema JW, de Roos A, Smit JW, Lamb HJ. Very-low-calorie diet increases myocardial triglyceride content and decreases diastolic left ventricular function in type 2 diabetes with cardiac complications. Diabetes Care 37: e1-e2, 2014.
13. Jonker JT, Snel M, Hammer S, Jazet IM, van der Meer RW, Pijl H, Meinders AE, de Roos A, Smit JW, Romijn JA, Lamb HJ. Sustained cardiac remodeling after a short-term very low calorie diet in type 2 diabetes mellitus patients. Int J Cardiovasc Imaging 30: 121-127, 2014.
14. Kamga-Ngande CN, Carpentier AC, Nadeau-Marcotte F, Ardilouze JL, Baillargeon JP, Bellabarba D, Houde G, Langlois MF. Effectiveness of a multidisciplinary program for management of obesity: the Unite d'Enseignement, de Traitement et de Recherche sur l'Obesite (UETRO) database study. Metab Syndr Relat Disord 7: 297-304, 2009.
15. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91: 4689-4695, 2006.
16. Kennedy ET, Bowman SA, Powell R. Dietary-fat intake in the US population. J Am Coll Nutr 18: 207-212, 1999.
17. Klein LJ, Visser FC, Knaapen P, Peters JH, Teule GJ, Visser CA, Lammertsma AA. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med 28: 651-668, 2001.
18. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403, 2002.
19. Knuuti J, Takala TO, Nagren K, Sipila H, Turpeinen AK, Uusitupa MI, Nuutila P. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia 44: 184-187, 2001.
20. Labbe SM, Croteau E, Grenier-Larouche T, Frisch F, Ouellet R, Langlois R, Guerin B, Turcotte EE, Carpentier AC. Normal postprandial nonesterified fatty acid uptake in muscles despite increased circulating Fatty acids in type 2 diabetes. Diabetes 60: 408-415, 2011.
21. Labbe SM, Grenier-Larouche T, Croteau E, Normand-Lauziere F, Frisch F, Ouellet R, Guerin B, Turcotte EE, Carpentier AC. Organspecific dietary fatty acid uptake in humans using positron emission tomography coupled to computed tomography. Am J Physiol Endocrinol Metab 300: E445-E453, 2011.
22. Labbe SM, Grenier-Larouche T, Noll C, Phoenix S, Guerin B, Turcotte EE, Carpentier AC. Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans. Diabetes 61: 2701-2710, 2012.
23. Lehto HR, Parkka J, Borra R, Tuunanen H, Lepomaki V, Parkkola R, Knuuti J, Nuutila P, Iozzo P. Effects of acute and one-week Fatty Acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels. J Clin Endocrinol Metab 97: 3277-3284, 2012.
24. Liu L, Shi X, Bharadwaj KG, Ikeda S, Yamashita H, Yagyu H, Schaffer JE, Yu YH, Goldberg IJ. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J Biol Chem 284: 36312-36323, 2009.
25. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116: 1170-1175, 2007.
26. Menard SL, Croteau E, Sarrhini O, Gelinas R, Brassard P, Ouellet R, Bentourkia M, van Lier JE, Des RC, Lecomte R, Carpentier AC. Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. Am J Physiol Endocrinol Metab 298: E1049-E1057, 2010.
27. Muller MJ, Bosy-Westphal A. Adaptive thermogenesis with weight loss in humans. Obesity 21: 218-228, 2013.
28. Nelson RH, Prasad A, Lerman A, Miles JM. Myocardial uptake of circulating triglycerides in nondiabetic patients with heart disease. Diabetes 56: 527-530, 2007.
29. Normand-Lauziere F, Frisch F, Labbe SM, Bherer P, Gagnon R, Cunnane SC, Carpentier AC. Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects. PLoSONE 5: e10956, 2010.
30. Oakes ND, Thalen P, Aasum E, Edgley A, Larsen T, Furler SM, Ljung B, Severson D. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes. Am J Physiol Endocrinol Metab 290: E870-E881, 2006.
31. Ouellet V, Labbe SM, Blondin DP, Phoenix S, Guerin B, Haman F, Turcotte EE, Richard D, Carpentier AC. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 122: 545-552, 2012.
32. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations J Cereb Blood Flow Metab 5: 584-590, 1985.
33. Ravikumar B, Carey PE, Snaar JE, Deelchand DK, Cook DB, Neely RD, English PT, Firbank MJ, Morris PG, Taylor R. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 288: E789-E797, 2005.
34. Rider OJ, Francis JM, Tyler D, Byrne J, Clarke K, Neubauer S. Effects of weight loss on myocardial energetics and diastolic function in obesity. Int J Cardiovasc Imaging 29: 1043-1050, 2013.
35. Santosa S, Hensrud DD, Votruba SB, Jensen MD. The influence of sex and obesity phenotype on meal fatty acid metabolism before and after weight loss. Am J Clin Nutr 88: 1134-1141, 2008.
36. Schrauwen-Hinderling VB, Meex RC, Hesselink MK, van de Weijer T, Leiner T, Schar M, Lamb HJ, Wildberger JE, Glatz JF, Schrauwen P, Kooi ME. Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction (Abstract). Cardiovasc Diabetol 10: 47, 2011.
37. Szczepaniak LS, Victor RG, Orci L, Unger RH. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 101: 759-767, 2007.
38. Teusink B, Voshol PJ, Dahlmans VE, Rensen PC, Pijl H, Romijn JA, Havekes LM. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 52: 614-620, 2003.
39. Turpeinen AK, Takala TO, Nuutila P, Axelin T, Luotolahti M, Haaparanta M, Bergman J, Hamalainen H, Iida H, Maki M, Uusitupa MI, Knuuti J. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R, S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes 48: 1245-1250, 1999.
40. van de Weijer T, Schrauwen-Hinderling VB, Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res 92: 10-18, 2011.
41. van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, Van dV, Boer C, Ouwens DM, Diamant M. Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography (Abstract). Cardiovasc Diabetol 8: 39, 2009.
42. van den HJ, Burchert W, Borner AR, Fricke H, Kuhnel G, Meyer GJ, Otto D, Weckesser E, Wolpers HG, Knapp WH. [1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med 42: 1174-1182, 2001.
43. van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de RA, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 119: 2069-2077, 2009.
44. van Schinkel LD, Sleddering MA, Lips MA, Jonker JT, de Roos A, Lamb HJ, Jazet IM, Pijl H, Smit JW. Effects of bariatric surgery on pericardial ectopic fat depositions and cardiovascular function. Clin Endocrinol In press.
45. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart 98: 1763-1777, 2012.
46. Viljanen AP, Karmi A, Borra R, Parkka JP, Lepomaki V, Parkkola R, Lautamaki R, Jarvisalo M, Taittonen M, Ronnemaa T, Iozzo P, Knuuti J, Nuutila P, Raitakari OT. Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults. Am J Cardiol 103: 1721-1726, 2009.
47. Welch MJ, Lewis JS, Kim J, Sharp TL, Dence CS, Gropler RJ, Herrero P. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study. J Nucl Med 47: 689-697, 2006.